4
Changes in Ownership
ARS Pharmaceuticals, Inc. Filed Acc 0001415889-24-029377
Chief Business Officer sold 144,605 shares at an average $12.23 ($1,768,093)
- Chief Business Officer acquired 144,605 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Chakma Justin Chief Business Officer | 2024-12-12 | Option exercise | +117,333 | $0.84 | $98,560 | 253,713 | D |
| Chakma Justin Chief Business Officer | 2024-12-12 | Sale | −117,333 | $12.27 | $1,439,124 | 136,380 | D |
| Chakma Justin Chief Business Officer | 2024-12-13 | Option exercise | +27,272 | $1.44 | $39,272 | 163,652 | D |
| Chakma Justin Chief Business Officer | 2024-12-13 | Sale | −27,272 | $12.06 | $328,969 | 136,380 | D |
| Derivatives | |||||||
| Chakma Justin Chief Business Officer | 2024-12-12 | Option exercise · Stock Option (Right to Buy) | −117,333 | 119,047 | D | ||
| Chakma Justin Chief Business Officer | 2024-12-13 | Option exercise · Stock Option (Right to Buy) | −27,272 | 55,461 | D | ||
| Open-market sales · 144,605 sh · avg $12.23 · $1,768,093 | |||||||
Loading xslF345X05/form4-12142024_121217.xml…